Get the Stockscreener App
5.05
0.40%
0.02
After Hours:
5.12
0.07
+1.39%
Nutriband Inc stock is traded at $5.05, with a volume of 3,593.
It is up +0.40% in the last 24 hours and down -23.14% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$5.03
Open:
$5.05
24h Volume:
3,593
Relative Volume:
0.02
Market Cap:
$55.09M
Revenue:
$2.09M
Net Income/Loss:
$-5.28M
P/E Ratio:
-7.5373
EPS:
-0.67
Net Cash Flow:
$-3.64M
1W Performance:
+6.99%
1M Performance:
-23.14%
6M Performance:
-28.87%
1Y Performance:
+18.27%
1-Day Range:
$5.02
$5.15
1-Week Range:
$4.5929
$5.20
52-Week Range:
$3.20
$11.78
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Compare NTRB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
5.05 | 55.09M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Noble Capital Markets | Outperform |
Nutriband Inc Stock (NTRB) Latest News
Nutriband (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Nutriband Advances Opioid Safety with Innovative AVERSA Technology - citybuzz -
Nutriband (NTRB) Achieves Key Patent Approval in Macao for AVERS - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology | NTRB Stock News - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology - GlobeNewswire
Nutriband secures Macao patent for drug abuse deterrent tech By Investing.com - Investing.com South Africa
Nutriband Receives Patent for Abuse, Misuse Deterrent Transdermal Systems in Macao - marketscreener.com
Nutriband secures Macao patent for drug abuse deterrent tech - Investing.com
Revolutionary Opioid Safety Tech: Nutriband Secures 46-Country Patent Protection - Stock Titan
Nutriband Partners with Charlotte FC for Brand Visibility - TipRanks
Nutriband (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand Visibility - The Globe and Mail
(NTRB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M - ACCESS Newswire
UPDATENutriband Signs Associate Partnership with Charlotte FC - The Manila Times
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC - Bluefield Daily Telegraph
Nutriband Expands Market Reach: Strategic Partnership With Charlotte FC Spotlights Pain Management Innovation - Stock Titan
Nutriband partners with Charlotte FC to boost brand visibility By Investing.com - Investing.com South Africa
Nutriband Signs Partnership Agreement with Charlotte FC - GlobeNewswire
Nutriband (NTRB) Secures Partnership with Charlotte FC - GuruFocus
Nutriband partners with Charlotte FC to boost brand visibility - Investing.com India
Strategic Alliance: Nutriband Brings Revolutionary Pain Management Tech to Major League Soccer - Stock Titan
Nutriband (NASDAQ:NTRBW) Trading Up 2.6% – Time to Buy? - Defense World
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica - ACCESS Newswire
(NTRB) Proactive Strategies - news.stocktradersdaily.com
Critical Analysis: Pathfinder Cell Therapy (OTCMKTS:PFND) and Nutriband (NASDAQ:NTRB) - The AM Reporter
How To Trade (NTRB) - Stock Traders Daily
3 Reasons to Sell UAL and 1 Stock to Buy Instead - The Globe and Mail
Breakeven On The Horizon For Nutriband Inc. (NASDAQ:NTRB) - Simply Wall St
When the Price of (NTRB) Talks, People Listen - Stock Traders Daily
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch - ACCESS Newswire
Nutriband Inc, Orlando - Florida Trend
Nutriband Inc. to Present at the Emerging Growth Conference on May 25 - ACCESS Newswire
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st - ACCESS Newswire
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May - ACCESS Newswire
Nutriband Inc. To Participate in The Benzinga All Access Event on February 4 - ACCESS Newswire
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology - ACCESS Newswire
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - ACCESS Newswire
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M - ACCESS Newswire
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company - ACCESS Newswire
(NTRB) Long Term Investment Analysis - news.stocktradersdaily.com
Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary - ACCESS Newswire
Nutriband Receives Certificate of Registration for - GlobeNewswire
Nutriband secures trademark for drug abuse deterrent tech By Investing.com - Investing.com Nigeria
Nutriband secures trademark for drug abuse deterrent tech - Investing.com
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development. - The Manila Times
Can This New Trademark Help Nutriband Capture a $200M Drug Delivery Market? - StockTitan
Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3 - ACCESS Newswire
Nutriband Stock Soars to 52-Week High of $9.6 Amidst Strong Growth - MSN
This Surging Pharma Company Could Hit Profitability by 2027 - Elblog.pl
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):